Vedolizumab是一種整聯(lián)蛋白受體拮抗劑,是一種在中國(guó)倉(cāng)鼠卵巢細(xì)胞中產(chǎn)生的人源化IgG1單克隆抗體,可與人α4β7整聯(lián)蛋白結(jié)合。Vedolizumab的分子量約為147千道爾頓。 Vedolizumab生物類似藥-超低內(nèi)毒素該產(chǎn)品同種型對(duì)照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液:ICH3001-100ml,nICH3002-100ml,nICH3003-100ml, 濃度:1.0 - 5.0 mg/ml 純度:>95% by SDS-PAGE and HPLC 內(nèi)毒素:≤ 0.1 EU/mg as determined by the LAL method 制劑:Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.